Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ran Friedman

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Journal of Molecular Biology|October 25, 2011
Surfactant effects on amyloid aggregation kineticsRan Friedman, Amedeo Caflisch
Proteins|May 24, 2008
Pepsinogen-like activation intermediate of plasmepsin II revealed by molecular dynamics analysisRan Friedman, Amedeo Caflisch
Proteins|January 30, 2010
On the orientation of the catalytic dyad in aspartic proteasesRan Friedman, Amedeo Caflisch
Journal of Chemical Information and Modeling|March 31, 2025
Estimation of Absolute Binding Free Energies for Drugs That Bind Multiple ProteinsErik Lindahl, Ran Friedman
Journal of Chemical Theory and Computation|October 14, 2021
Activation of Abl1 Kinase Explored Using Well-Tempered Metadynamics Simulations on an Essential Dynamics Sampled PathBaswanth Oruganti, Ran Friedman
Physical Chemistry Chemical Physics : PCCP|July 26, 2019
Conformational modifications induced by internal tandem duplications on the FLT3 kinase and juxtamembrane domainsGuido Todde, Ran Friedman
Chemmedchem|May 28, 2009
Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoringRan Friedman, Amedeo Caflisch
The Journal of Physical Chemistry. B|June 28, 2019
Activation and Inactivation of the FLT3 Kinase: Pathway Intermediates and the Free Energy of TransitionGuido Todde, Ran Friedman
Bioorganic & Medicinal Chemistry Letters|November 3, 2025
Strengths and limitations of Ba/F3 cells in modelling FLT3-driven AML resistanceJingmei Yang, Ran Friedman
Bioorganic Chemistry|April 10, 2025
Inhibition of FLT3-induced signalling in refractory acute myeloid leukaemiaJingmei Yang, Ran Friedman
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Journal of Molecular Biology|October 25, 2011
Surfactant effects on amyloid aggregation kineticsRan Friedman, Amedeo Caflisch
Proteins|May 24, 2008
Pepsinogen-like activation intermediate of plasmepsin II revealed by molecular dynamics analysisRan Friedman, Amedeo Caflisch
Proteins|January 30, 2010
On the orientation of the catalytic dyad in aspartic proteasesRan Friedman, Amedeo Caflisch
Journal of Chemical Information and Modeling|March 31, 2025
Estimation of Absolute Binding Free Energies for Drugs That Bind Multiple ProteinsErik Lindahl, Ran Friedman
Journal of Chemical Theory and Computation|October 14, 2021
Activation of Abl1 Kinase Explored Using Well-Tempered Metadynamics Simulations on an Essential Dynamics Sampled PathBaswanth Oruganti, Ran Friedman
Physical Chemistry Chemical Physics : PCCP|July 26, 2019
Conformational modifications induced by internal tandem duplications on the FLT3 kinase and juxtamembrane domainsGuido Todde, Ran Friedman
Chemmedchem|May 28, 2009
Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoringRan Friedman, Amedeo Caflisch
The Journal of Physical Chemistry. B|June 28, 2019
Activation and Inactivation of the FLT3 Kinase: Pathway Intermediates and the Free Energy of TransitionGuido Todde, Ran Friedman
Bioorganic & Medicinal Chemistry Letters|November 3, 2025
Strengths and limitations of Ba/F3 cells in modelling FLT3-driven AML resistanceJingmei Yang, Ran Friedman
Bioorganic Chemistry|April 10, 2025
Inhibition of FLT3-induced signalling in refractory acute myeloid leukaemiaJingmei Yang, Ran Friedman
Pageof 10